Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketorolac for Postoperative Pain
NCT01347853Phase 3Completed
- Sponsor
- Egalet
- Start
- Jun 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ketorolac tromethamine with Placebo (2 arms). Primary endpoint: Summed Pain Intensity Difference at 6 hours. Started Jun 2003; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01347853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347853.